Ligand Pharmaceuticals reported $1.77M in Interest Income for its fiscal quarter ending in March of 2025.


Interest Income Change Date
Arrowhead Research USD 9.62M 2.01M Mar/2025
Baxter International USD 17M 7M Mar/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences 73M 21M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
Glaxosmithkline 50M 78M Jun/2025
Insmed 0 0 Mar/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
Ligand Pharmaceuticals USD 1.77M 160K Mar/2025
MacroGenics 1.41M 1.41M Jun/2025
Merck USD 109M 37M Mar/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 156M 13M Jun/2025
Veracyte USD 2.76M 99K Mar/2025